STOCK TITAN
  1. Home
  2. Sec-filings
  3. PSTV
  4. [EFFECT] PLUS THERAPEUTICS, INC. SEC Filing

[EFFECT] PLUS THERAPEUTICS, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 13, 2026 5:00 P.M.
Form: S-1
CIK: 0001095981
Company Name: PLUS THERAPEUTICS, INC.
File Number: 333-292637

Source: View Original Filing on SEC EDGAR

Stock PSTV logo
Plus Therapeutics Inc

NASDAQ:PSTV

PSTV Rankings

#5677 Ranked by Market Cap
N/A Ranked by Dividends

PSTV Latest News

Jan 14, 2026
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
Jan 8, 2026
Plus Therapeutics Announces Read Out of Type B Meeting with the FDA with Goal of Accelerating Approval of REYOBIQ™ for Leptomeningeal Metastases
Dec 11, 2025
Plus Therapeutics Expands CNSide Assay Platform to State of California
Dec 9, 2025
Plus Therapeutics Announces Expansion of CNSide Team and Issuance of Inducement Grants
Dec 4, 2025
Plus Therapeutics Highlights Three REYOBIQ™ Clinical Data Presentations at 2025 WFNOS/SNO Annual Meeting

PSTV Latest SEC Filings

Nov 17, 2025
[8-K] PLUS THERAPEUTICS, INC. Reports Material Event
Nov 5, 2025
[Form 4] PLUS THERAPEUTICS, INC. Insider Trading Activity
Oct 30, 2025
[10-Q] PLUS THERAPEUTICS, INC. Quarterly Earnings Report
Oct 30, 2025
[8-K] PLUS THERAPEUTICS, INC. Reports Material Event
Oct 21, 2025
[8-K] PLUS THERAPEUTICS, INC. Reports Material Event

PSTV Stock Data

40.34M
135.31M
1.77%
1.27%
4.7%
Biotechnology
Surgical & Medical Instruments & Apparatus
Link
United States
AUSTIN